Carregant...
Dendritic cell-based vaccines: barriers and opportunities
Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option. However, DC-based vaccines face sever...
Guardat en:
| Publicat a: | Future Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4260651/ https://ncbi.nlm.nih.gov/pubmed/23130928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.12.125 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|